NASDAQ:NAYA - Nasdaq - US44984F4019 - Common Stock - Currency: USD
2.2
+0.17 (+8.37%)
The current stock price of NAYA is 2.2 USD. In the past month the price decreased by -7.56%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.83 | 230.75B | ||
ISRG | INTUITIVE SURGICAL INC | 71.61 | 196.08B | ||
BSX | BOSTON SCIENTIFIC CORP | 38.76 | 154.77B | ||
SYK | STRYKER CORP | 30.31 | 144.95B | ||
MDT | MEDTRONIC PLC | 15.35 | 108.26B | ||
BDX | BECTON DICKINSON AND CO | 12.29 | 49.72B | ||
EW | EDWARDS LIFESCIENCES CORP | 29.27 | 44.74B | ||
IDXX | IDEXX LABORATORIES INC | 43.94 | 40.59B | ||
RMD | RESMED INC | 27.07 | 36.04B | ||
DXCM | DEXCOM INC | 51.45 | 33.29B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 15.13 | 31.86B | ||
STE | STERIS PLC | 26.37 | 24.20B |
INVO Fertility Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Sarasota, Florida and currently employs 25 full-time employees. The company went IPO on 2008-11-11. INVO Fertility Inc., formerly NAYA Biosciences, Inc., is a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition, and operation of fertility clinics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution into third-party owned and operated fertility clinics. The INVOcell is a proprietary medical device that allow fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
NAYA BIOSCIENCES INC
5582 Broadcast Court
Sarasota FLORIDA US
Employees: 25
Phone: 19788789505
The current stock price of NAYA is 2.2 USD. The price increased by 8.37% in the last trading session.
The exchange symbol of NAYA BIOSCIENCES INC is NAYA and it is listed on the Nasdaq exchange.
NAYA stock is listed on the Nasdaq exchange.
7 analysts have analysed NAYA and the average price target is 6.12 USD. This implies a price increase of 178.18% is expected in the next year compared to the current price of 2.2. Check the NAYA BIOSCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
NAYA BIOSCIENCES INC (NAYA) has a market capitalization of 1.47M USD. This makes NAYA a Nano Cap stock.
NAYA BIOSCIENCES INC (NAYA) currently has 25 employees.
NAYA BIOSCIENCES INC (NAYA) has a support level at 1.83 and a resistance level at 2.27. Check the full technical report for a detailed analysis of NAYA support and resistance levels.
The Revenue of NAYA BIOSCIENCES INC (NAYA) is expected to grow by 125.23% in the next year. Check the estimates tab for more information on the NAYA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NAYA does not pay a dividend.
NAYA BIOSCIENCES INC (NAYA) will report earnings on 2025-05-13.
NAYA BIOSCIENCES INC (NAYA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.96).
ChartMill assigns a fundamental rating of 1 / 10 to NAYA. NAYA may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months NAYA reported a non-GAAP Earnings per Share(EPS) of -2.96. The EPS increased by 76.18% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -43.87% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 83% to NAYA. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of -3770% and a revenue growth 125.23% for NAYA